Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | SRC | P12931 | 1/20 | 0.31 |
| ▸ | DHFR | P00374 | 1/20 | 0.30 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19686149 | 0.91 | — | — | |
| SCHEMBL19679950 | 0.87 | SRC (0.38) | ALDH1A1SRC | |
| SCHEMBL19679945 | 0.83 | PSEN1 (0.38) | ALDH1A1MAPTNPSR1 | |
| SCHEMBL19679948 | 0.79 | MEN1 (0.38) | PGRALDH1A1MEN1MAPTKMT2A | |
| SCHEMBL19679953 | 0.79 | SRC (0.32) | ALDH1A1SRC | |
| SCHEMBL19679951 | 0.77 | SRC (0.31) | ALDH1A1SRC | |
| SCHEMBL18371200 | 0.76 | MEN1 (0.33) | SRCMEN1MAPTKMT2ANPSR1 | |
| SCHEMBL19679949 | 0.76 | PSEN1 (0.36) | ALDH1A1MAPT | |
| SCHEMBL19685696 | 0.75 | ALDH1A1 (0.37) | ALDH1A1MEN1MAPTKMT2ANPSR1 | |
| SCHEMBL19679952 | 0.75 | PSEN1 (0.37) | ALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190211035-A1 | N-Annulated Perylene Diimide Dimers with Active Pyrollic N-H Bonds | UTI LIMITED PARTNERSHIP (CA) | 2019-07-11 | — | — | US | disclosed |
| US-20170352812-A1 | NITROGEN ANNULATED PERYLENE DIIMIDES FOR USE AS ELECTRON TRANSPORT MATERIALS IN ORGANIC ELECTRONIC DEVICES | UTI LIMITED PARTNERSHIP (CA) | 2017-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170352812-A1 | NITROGEN ANNULATED PERYLENE DIIMIDES FOR USE AS ELECTRON TRANSPORT MATERIALS IN ORGANIC ELECTRONIC DEVICES | PPOX, NOXO1, NDUFV2 | PGR 438/4885ALDH1A1 1143/4885SRC 3426/4885 |
| US-20190211035-A1 | N-Annulated Perylene Diimide Dimers with Active Pyrollic N-H Bonds | PPOX, NOXO1, NOD1 | PGR 377/4885ALDH1A1 1850/4885SRC 2983/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.